TY - JOUR AU - Arromdee, E. AU - Michet, C. J. AU - Crowson, C. S. AU - O'Fallon, W. M. AU - Gabriel, S. E. PY - 2002 DA - 2002// TI - Epidemiology of gout: is the incidence rising? JO - J Rheumatol VL - 29 ID - Arromdee2002 ER - TY - JOUR AU - Wallace, K. L. AU - Riedel, A. A. AU - Joseph-Ridge, N. AU - Wortmann, R. PY - 2004 DA - 2004// TI - Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population JO - J Rheumatol VL - 31 ID - Wallace2004 ER - TY - JOUR AU - Lawrence, R. C. AU - Felson, D. T. AU - Helmick, C. G. AU - Arnold, L. M. AU - Choi, H. AU - Deyo, R. A. AU - Gabriel, S. AU - Hirsch, R. AU - Hochberg, M. C. AU - Hunder, G. G. AU - Jordan, J. M. AU - Katz, J. N. AU - Kremers, H. M. AU - Wolfe, F. PY - 2008 DA - 2008// TI - Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II JO - Arthritis Rheum VL - 58 UR - https://doi.org/10.1002/art.23176 DO - 10.1002/art.23176 ID - Lawrence2008 ER - TY - STD TI - United States Census Bureau. Table 3. Annual Estimates of the Resident Population by Sex, Race, and Hispanic Origin for the United States: April 1, 2000 to July 1, 2009 (NC-EST2009-03). 2010, Available at: http://www.census.gov/popest/national/asrh/NC-EST2009-srh.html. Accessed February 14, 2011 UR - http://www.census.gov/popest/national/asrh/NC-EST2009-srh.html ID - ref4 ER - TY - JOUR AU - Hochberg, M. C. AU - Thomas, J. AU - Thomas, D. J. AU - Mead, L. AU - Levine, D. M. AU - Klag, M. J. PY - 1995 DA - 1995// TI - Racial differences in the incidence of gout. The role of hypertension JO - Arthritis Rheum VL - 38 UR - https://doi.org/10.1002/art.1780380508 DO - 10.1002/art.1780380508 ID - Hochberg1995 ER - TY - JOUR AU - Lawrence, R. C. AU - Helmick, C. G. AU - Arnett, F. C. AU - Deyo, R. A. AU - Felson, D. T. AU - Giannini, E. H. AU - Heyse, S. P. AU - Hirsch, R. AU - Hochberg, M. C. AU - Hunder, G. G. AU - Liang, M. H. AU - Pillemer, S. R. AU - Steen, V. D. AU - Wolfe, F. PY - 1998 DA - 1998// TI - Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States JO - Arthritis Rheum VL - 41 UR - https://doi.org/3.0.CO;2-V DO - 3.0.CO;2-V ID - Lawrence1998 ER - TY - JOUR AU - Krishnan, E. AU - Lienesch, D. AU - Kwoh, C. K. PY - 2008 DA - 2008// TI - Gout in ambulatory care settings in the United States JO - J Rheumatol VL - 35 ID - Krishnan2008 ER - TY - STD TI - National Center for Health Statistics. Health, United States, 2009: With special feature on medical technology. 2010, Hyattsville, MD: Centers for Disease Control. U.S. Department of Health and Human Services ID - ref8 ER - TY - JOUR AU - Batson, B. AU - Belletti, D. AU - Wogen, J. PY - 2010 DA - 2010// TI - Effect of African American race on hypertension management: a real-world observational study among 28 US physician practices JO - Ethn Dis VL - 20 ID - Batson2010 ER - TY - JOUR AU - Choi, H. K. AU - Mount, D. B. AU - Reginato, A. M. PY - 2005 DA - 2005// TI - Pathogenesis of gout JO - Ann Intern Med VL - 143 UR - https://doi.org/10.7326/0003-4819-143-7-200510040-00009 DO - 10.7326/0003-4819-143-7-200510040-00009 ID - Choi2005 ER - TY - JOUR AU - Terkeltaub, R. A. PY - 2003 DA - 2003// TI - Clinical practice. Gout JO - N Engl J Med VL - 349 UR - https://doi.org/10.1056/NEJMcp030733 DO - 10.1056/NEJMcp030733 ID - Terkeltaub2003 ER - TY - JOUR AU - Becker, M. A. AU - Chohan, S. PY - 2008 DA - 2008// TI - We can make gout management more successful now JO - Curr Opin Rheumatol VL - 20 UR - https://doi.org/10.1097/BOR.0b013e3282f54d03 DO - 10.1097/BOR.0b013e3282f54d03 ID - Becker2008 ER - TY - JOUR AU - Shoji, A. AU - Yamanaka, H. AU - Kamatani, N. PY - 2004 DA - 2004// TI - A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy JO - Arthritis Rheum VL - 51 UR - https://doi.org/10.1002/art.20405 DO - 10.1002/art.20405 ID - Shoji2004 ER - TY - JOUR AU - Becker, M. A. AU - Schumacher, H. R. AU - MacDonald, P. A. AU - Lloyd, E. AU - Lademacher, C. PY - 2009 DA - 2009// TI - Clinical efficacy and safety of successful long-term urate lowering with febuxostat or allopurinol in subjects with gout JO - J Rheumatol VL - 36 UR - https://doi.org/10.3899/jrheum.080814 DO - 10.3899/jrheum.080814 ID - Becker2009 ER - TY - JOUR AU - Schumacher, H. R. AU - Becker, M. A. AU - Lloyd, E. AU - MacDonald, P. A. AU - Lademacher, C. PY - 2009 DA - 2009// TI - Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study JO - Rheumatology (Oxford) VL - 48 UR - https://doi.org/10.1093/rheumatology/ken457 DO - 10.1093/rheumatology/ken457 ID - Schumacher2009 ER - TY - JOUR AU - Bartels, E. C. AU - Matossian, G. S. PY - 1959 DA - 1959// TI - Gout: six-year follow-up on probenecid (benemid) therapy JO - Arthritis Rheum VL - 2 UR - https://doi.org/3.0.CO;2-8 DO - 3.0.CO;2-8 ID - Bartels1959 ER - TY - JOUR AU - Sarawate, C. A. AU - Brewer, K. K. AU - Yang, W. AU - Patel, P. A. AU - Schumacher, H. R. AU - Saag, K. G. AU - Bakst, A. W. PY - 2006 DA - 2006// TI - Gout medication treatment patterns and adherence to standards of care from a managed care perspective JO - Mayo Clin Proc VL - 81 UR - https://doi.org/10.4065/81.7.925 DO - 10.4065/81.7.925 ID - Sarawate2006 ER - TY - JOUR AU - Zhang, W. AU - Doherty, M. AU - Bardin, T. AU - Pascual, E. AU - Barskova, V. AU - Conaghan, P. AU - Gerster, J. AU - Jacobs, J. AU - Leeb, B. AU - Liote, F. AU - McCarthy, G. AU - Netter, P. AU - Nuki, G. AU - Perez-Ruiz, F. AU - Pignone, A. AU - Pimentao, J. AU - Punzi, L. AU - Roddy, E. AU - Uhlig, T. AU - Zimmermann-Gorska, I. PY - 2006 DA - 2006// TI - EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) JO - Ann Rheum Dis VL - 65 UR - https://doi.org/10.1136/ard.2006.055269 DO - 10.1136/ard.2006.055269 ID - Zhang2006 ER - TY - JOUR AU - Dalbeth, N. AU - Kumar, S. AU - Stamp, L. AU - Gow, P. PY - 2006 DA - 2006// TI - Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout JO - J Rheumatol VL - 33 ID - Dalbeth2006 ER - TY - STD TI - UloricĀ® Full Prescribing Information. 2011, Deerfield, IL: Takeda Pharmaceuticals North America, Inc. ID - ref20 ER - TY - JOUR AU - Becker, M. A. AU - Schumacher, H. R. AU - Wortmann, R. L. AU - MacDonald, P. A. AU - Eustace, D. AU - Palo, W. A. AU - Streit, J. AU - Joseph-Ridge, N. PY - 2005 DA - 2005// TI - Febuxostat compared with allopurinol in patients with hyperuricemia and gout JO - N Engl J Med VL - 353 UR - https://doi.org/10.1056/NEJMoa050373 DO - 10.1056/NEJMoa050373 ID - Becker2005 ER - TY - JOUR AU - Schumacher, H. R. AU - Becker, M. A. AU - Wortmann, R. L. AU - Macdonald, P. A. AU - Hunt, B. AU - Streit, J. AU - Lademacher, C. AU - Joseph-Ridge, N. PY - 2008 DA - 2008// TI - Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial JO - Arthritis Rheum VL - 59 UR - https://doi.org/10.1002/art.24209 DO - 10.1002/art.24209 ID - Schumacher2008 ER - TY - JOUR AU - Becker, M. A. AU - Schumacher, H. R. AU - Espinoza, L. R. AU - Wells, A. F. AU - Macdonald, P. AU - Lloyd, E. AU - Lademacher, C. PY - 2010 DA - 2010// TI - The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial JO - Arthritis Res Ther VL - 12 UR - https://doi.org/10.1186/ar2978 DO - 10.1186/ar2978 ID - Becker2010 ER - TY - JOUR AU - Wallace, S. L. AU - Robinson, H. AU - Masi, A. T. AU - Decker, J. L. AU - McCarty, D. J. AU - Yu, T. F. PY - 1977 DA - 1977// TI - Preliminary criteria for the classification of the acute arthritis of primary gout JO - Arthritis Rheum VL - 20 UR - https://doi.org/10.1002/art.1780200320 DO - 10.1002/art.1780200320 ID - Wallace1977 ER - TY - JOUR AU - Cockcroft, D. W. AU - Gault, M. H. PY - 1976 DA - 1976// TI - Prediction of creatinine clearance from serum creatinine JO - Nephron VL - 16 UR - https://doi.org/10.1159/000180580 DO - 10.1159/000180580 ID - Cockcroft1976 ER - TY - JOUR AU - Robert, S. AU - Zarowitz, B. J. AU - Peterson, E. L. AU - Dumler, F. PY - 1993 DA - 1993// TI - Predictability of creatinine clearance estimates in critically ill patients JO - Crit Care Med VL - 21 UR - https://doi.org/10.1097/00003246-199310000-00016 DO - 10.1097/00003246-199310000-00016 ID - Robert1993 ER - TY - JOUR AU - Belle, D. J. AU - Singh, H. PY - 2008 DA - 2008// TI - Genetic factors in drug metabolism JO - Am Fam Physician VL - 77 ID - Belle2008 ER - TY - JOUR AU - Cavallari, L. H. AU - Langaee, T. Y. AU - Momary, K. M. AU - Shapiro, N. L. AU - Nutescu, E. A. AU - Coty, W. A. AU - Viana, M. A. AU - Patel, S. R. AU - Johnson, J. A. PY - 2010 DA - 2010// TI - Genetic and clinical predictors of warfarin dose requirements in African Americans JO - Clin Pharmacol Ther VL - 87 UR - https://doi.org/10.1038/clpt.2009.223 DO - 10.1038/clpt.2009.223 ID - Cavallari2010 ER - TY - JOUR AU - Villeneuve, L. AU - Girard, H. AU - Fortier, L. C. AU - Gagne, J. F. AU - Guillemette, C. PY - 2003 DA - 2003// TI - Novel functional polymorphisms in the UGT1A7 and UGT1A9 glucuronidating enzymes in Caucasian and African-American subjects and their impact on the metabolism of 7-ethyl-10-hydroxycamptothecin and flavopiridol anticancer drugs JO - J Pharmacol Exp Ther VL - 307 UR - https://doi.org/10.1124/jpet.103.054072 DO - 10.1124/jpet.103.054072 ID - Villeneuve2003 ER - TY - JOUR AU - Kaniwa, N. AU - Kurose, K. AU - Jinno, H. AU - Tanaka-Kagawa, T. AU - Saito, Y. AU - Saeki, M. AU - Sawada, J. AU - Tohkin, M. AU - Hasegawa, R. PY - 2005 DA - 2005// TI - Racial variability in haplotype frequencies of UGT1A1 and glucuronidation activity of a novel single nucleotide polymorphism 686C > T (P229L) found in an African-American JO - Drug Metab Dispos VL - 33 UR - https://doi.org/10.1124/dmd.104.001800 DO - 10.1124/dmd.104.001800 ID - Kaniwa2005 ER - TY - JOUR AU - Dickmann, L. J. AU - Rettie, A. E. AU - Kneller, M. B. AU - Kim, R. B. AU - Wood, A. J. AU - Stein, C. M. AU - Wilkinson, G. R. AU - Schwarz, U. I. PY - 2001 DA - 2001// TI - Identification and functional characterization of a new CYP2C9 variant (CYP2C9*5) expressed among African Americans JO - Mol Pharmacol VL - 60 ID - Dickmann2001 ER - TY - JOUR AU - Dehghan, A. AU - Kottgen, A. AU - Yang, Q. AU - Hwang, S. J. AU - Kao, W. L. AU - Rivadeneira, F. AU - Boerwinkle, E. AU - Levy, D. AU - Hofman, A. AU - Astor, B. C. AU - Benjamin, E. J. AU - van Duijn, C. M. AU - Witteman, J. C. AU - Coresh, J. AU - Fox, C. S. PY - 2008 DA - 2008// TI - Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study JO - Lancet VL - 372 UR - https://doi.org/10.1016/S0140-6736(08)61343-4 DO - 10.1016/S0140-6736(08)61343-4 ID - Dehghan2008 ER - TY - CHAP AU - Rule, A. D. AU - de Andrade, M. AU - Matsumoto, M. AU - Mosley, T. H. AU - Kardia, S. AU - Turner, S. T. PY - 2010 DA - 2010// TI - Association between SLC2A9 transporter gene variants and uric acid phenotypes in African American and white families BT - Rheumatology (Oxford) ID - Rule2010 ER - TY - JOUR AU - Charles, B. A. AU - Shriner, D. AU - Doumatey, A. AU - Chen, G. AU - Zhou, J. AU - Huang, H. AU - Herbert, A. AU - Gerry, N. P. AU - Christman, M. F. AU - Adeyemo, A. AU - Rotimi, C. N. PY - 2011 DA - 2011// TI - A genome-wide association study of serum uric acid in African Americans JO - BMC Med Genomics VL - 4 UR - https://doi.org/10.1186/1755-8794-4-17 DO - 10.1186/1755-8794-4-17 ID - Charles2011 ER - TY - JOUR AU - Krishnan, E. PY - 2010 DA - 2010// TI - Inflammation, oxidative stress and lipids: the risk triad for atherosclerosis in gout JO - Rheumatology (Oxford) VL - 49 UR - https://doi.org/10.1093/rheumatology/keq037 DO - 10.1093/rheumatology/keq037 ID - Krishnan2010 ER - TY - JOUR AU - Kutzing, M. K. AU - Firestein, B. L. PY - 2008 DA - 2008// TI - Altered uric acid levels and disease states JO - J Pharmacol Exp Ther VL - 324 UR - https://doi.org/10.1124/jpet.107.129031 DO - 10.1124/jpet.107.129031 ID - Kutzing2008 ER - TY - JOUR AU - Krishnan, E. AU - Baker, J. F. AU - Furst, D. E. AU - Schumacher, H. R. PY - 2006 DA - 2006// TI - Gout and the risk of acute myocardial infarction JO - Arthritis Rheum VL - 54 UR - https://doi.org/10.1002/art.22014 DO - 10.1002/art.22014 ID - Krishnan2006 ER - TY - JOUR AU - Whelton, A. PY - 2010 DA - 2010// TI - Current and future therapeutic options for the management of gout JO - Am J Ther VL - 17 ID - Whelton2010 ER - TY - JOUR AU - Dehghan, A. AU - van Hoek, M. AU - Sijbrands, E. J. AU - Hofman, A. AU - Witteman, J. C. PY - 2008 DA - 2008// TI - High serum uric acid as a novel risk factor for type 2 diabetes JO - Diabetes Care VL - 31 UR - https://doi.org/10.2337/dc07-1276 DO - 10.2337/dc07-1276 ID - Dehghan2008 ER - TY - JOUR AU - De Vera, M. A. AU - Rahman, M. M. AU - Bhole, V. AU - Kopec, J. A. AU - Choi, H. K. PY - 2010 DA - 2010// TI - Independent impact of gout on the risk of acute myocardial infarction among elderly women: a population-based study JO - Ann Rheum Dis VL - 69 UR - https://doi.org/10.1136/ard.2009.122770 DO - 10.1136/ard.2009.122770 ID - De Vera2010 ER - TY - JOUR AU - Choi, H. K. AU - Curhan, G. PY - 2007 DA - 2007// TI - Independent impact of gout on mortality and risk for coronary heart disease JO - Circulation VL - 116 UR - https://doi.org/10.1161/CIRCULATIONAHA.107.703389 DO - 10.1161/CIRCULATIONAHA.107.703389 ID - Choi2007 ER - TY - JOUR AU - Krishnan, E. AU - Svendsen, K. AU - Neaton, J. D. AU - Grandits, G. AU - Kuller, L. H. PY - 2008 DA - 2008// TI - Long-term cardiovascular mortality among middle-aged men with gout JO - Arch Intern Med VL - 168 UR - https://doi.org/10.1001/archinte.168.10.1104 DO - 10.1001/archinte.168.10.1104 ID - Krishnan2008 ER - TY - JOUR AU - Mellen, P. B. AU - Bleyer, A. J. AU - Erlinger, T. P. AU - Evans, G. W. AU - Nieto, F. J. AU - Wagenknecht, L. E. AU - Wofford, M. R. AU - Herrington, D. M. PY - 2006 DA - 2006// TI - Serum uric acid predicts incident hypertension in a biethnic cohort: the atherosclerosis risk in communities study JO - Hypertension VL - 48 UR - https://doi.org/10.1161/01.HYP.0000249768.26560.66 DO - 10.1161/01.HYP.0000249768.26560.66 ID - Mellen2006 ER - TY - JOUR AU - Fang, J. AU - Alderman, M. H. PY - 2000 DA - 2000// TI - Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey JO - Jama VL - 283 UR - https://doi.org/10.1001/jama.283.18.2404 DO - 10.1001/jama.283.18.2404 ID - Fang2000 ER - TY - JOUR AU - Perez-Ruiz, F. AU - Atxotegi, J. AU - Hernando, I. AU - Calabozo, M. AU - Nolla, J. M. PY - 2006 DA - 2006// TI - Using serum urate levels to determine the period free of gouty symptoms after withdrawal of long-term urate-lowering therapy: a prospective study JO - Arthritis Rheum VL - 55 UR - https://doi.org/10.1002/art.22232 DO - 10.1002/art.22232 ID - Perez-Ruiz2006 ER - TY - JOUR AU - Perez-Ruiz, F. AU - Calabozo, M. AU - Pijoan, J. I. AU - Herrero-Beites, A. M. AU - Ruibal, A. PY - 2002 DA - 2002// TI - Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout JO - Arthritis Rheum VL - 47 UR - https://doi.org/10.1002/art.10511 DO - 10.1002/art.10511 ID - Perez-Ruiz2002 ER - TY - JOUR AU - Perez-Ruiz, F. AU - Liote, F. PY - 2007 DA - 2007// TI - Lowering serum uric acid levels: what is the optimal target for improving clinical outcomes in gout? JO - Arthritis Rheum VL - 57 UR - https://doi.org/10.1002/art.23007 DO - 10.1002/art.23007 ID - Perez-Ruiz2007 ER - TY - JOUR AU - Sanchez-Lozada, L. G. AU - Tapia, E. AU - Soto, V. AU - Avila-Casado, C. AU - Franco, M. AU - Wessale, J. L. AU - Zhao, L. AU - Johnson, R. J. PY - 2008 DA - 2008// TI - Effect of febuxostat on the progression of renal disease in 5/6 nephrectomy rats with and without hyperuricemia JO - Nephron Physiol VL - 108 UR - https://doi.org/10.1159/000127837 DO - 10.1159/000127837 ID - Sanchez-Lozada2008 ER - TY - JOUR AU - Sanchez-Lozada, L. G. AU - Tapia, E. AU - Soto, V. AU - Avila-Casado, C. AU - Franco, M. AU - Zhao, L. AU - Johnson, R. J. PY - 2008 DA - 2008// TI - Treatment with the xanthine oxidase inhibitor febuxostat lowers uric acid and alleviates systemic and glomerular hypertension in experimental hyperuricaemia JO - Nephrol Dial Transplant VL - 23 UR - https://doi.org/10.1093/ndt/gfm783 DO - 10.1093/ndt/gfm783 ID - Sanchez-Lozada2008 ER - TY - JOUR AU - Whelton, A. AU - Macdonald, P. A. AU - Zhao, L. AU - Hunt, B. AU - Gunawardhana, L. PY - 2011 DA - 2011// TI - Renal function in gout: long-term treatment effects of febuxostat JO - J Clin Rheumatol VL - 17 UR - https://doi.org/10.1097/RHU.0b013e318204aab4 DO - 10.1097/RHU.0b013e318204aab4 ID - Whelton2011 ER - TY - JOUR AU - Gibson, T. AU - Rodgers, V. AU - Potter, C. AU - Simmonds, H. A. PY - 1982 DA - 1982// TI - Allopurinol treatment and its effect on renal function in gout: a controlled study JO - Ann Rheum Dis VL - 41 UR - https://doi.org/10.1136/ard.41.1.59 DO - 10.1136/ard.41.1.59 ID - Gibson1982 ER - TY - JOUR AU - Kanbay, M. AU - Ozkara, A. AU - Selcoki, Y. AU - Isik, B. AU - Turgut, F. AU - Bavbek, N. AU - Uz, E. AU - Akcay, A. AU - Yigitoglu, R. AU - Covic, A. PY - 2007 DA - 2007// TI - Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearance, and proteinuria in patients with normal renal functions JO - Int Urol Nephrol VL - 39 UR - https://doi.org/10.1007/s11255-007-9253-3 DO - 10.1007/s11255-007-9253-3 ID - Kanbay2007 ER - TY - JOUR AU - Siu, Y. P. AU - Leung, K. T. AU - Tong, M. K. AU - Kwan, T. H. PY - 2006 DA - 2006// TI - Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level JO - Am J Kidney Dis VL - 47 UR - https://doi.org/10.1053/j.ajkd.2005.10.006 DO - 10.1053/j.ajkd.2005.10.006 ID - Siu2006 ER - TY - JOUR AU - Solomon, D. H. AU - Avorn, J. AU - Levin, R. AU - Brookhart, M. A. PY - 2008 DA - 2008// TI - Uric acid lowering therapy: prescribing patterns in a large cohort of older adults JO - Ann Rheum Dis VL - 67 UR - https://doi.org/10.1136/ard.2007.076182 DO - 10.1136/ard.2007.076182 ID - Solomon2008 ER - TY - JOUR AU - Jordan, J. M. AU - Lawrence, R. AU - Kington, R. AU - Fraser, P. AU - Karlson, E. AU - Lorig, K. AU - Liang, M. H. PY - 2002 DA - 2002// TI - Ethnic health disparities in arthritis and musculoskeletal diseases: report of a scientific conference JO - Arthritis Rheum VL - 46 UR - https://doi.org/10.1002/art.10480 DO - 10.1002/art.10480 ID - Jordan2002 ER - TY - STD TI - 2010 National Healthcare Disparities Report. Agency for Healthcare Research and Quality. 2011, AHRQ Publication No. 11-0005. [http://www.ahrq.gov/qual/qrdr10.htm] UR - http://www.ahrq.gov/qual/qrdr10.htm ID - ref56 ER - TY - JOUR AU - Lee, C. AU - Ayers, S. L. AU - Kronenfeld, J. J. PY - 2009 DA - 2009// TI - The association between perceived provider discrimination, healthcare utilization and health status in racial and ethnic minorities JO - Ethn Dis VL - 19 ID - Lee2009 ER - TY - JOUR AU - Constantinescu, F. AU - Goucher, S. AU - Weinstein, A. AU - Smith, W. AU - Fraenkel, L. PY - 2009 DA - 2009// TI - Understanding why rheumatoid arthritis patient treatment preferences differ by race JO - Arthritis Rheum VL - 61 UR - https://doi.org/10.1002/art.24338 DO - 10.1002/art.24338 ID - Constantinescu2009 ER - TY - JOUR AU - Constantinescu, F. AU - Goucher, S. AU - Weinstein, A. AU - Fraenkel, L. PY - 2009 DA - 2009// TI - Racial disparities in treatment preferences for rheumatoid arthritis JO - Med Care VL - 47 UR - https://doi.org/10.1097/MLR.0b013e31818af829 DO - 10.1097/MLR.0b013e31818af829 ID - Constantinescu2009 ER - TY - JOUR AU - Ang, D. C. AU - Monahan, P. O. AU - Cronan, T. A. PY - 2008 DA - 2008// TI - Understanding ethnic disparities in the use of total joint arthroplasty: application of the health belief model JO - Arthritis Rheum VL - 59 UR - https://doi.org/10.1002/art.23243 DO - 10.1002/art.23243 ID - Ang2008 ER - TY - JOUR AU - Becker, M. A. AU - MacDonald, P. A. AU - Hunt, B. J. AU - Lademacher, C. AU - Joseph-Ridge, N. PY - 2008 DA - 2008// TI - Determinants of the clinical outcomes of gout during the first year of urate-lowering therapy JO - Nucleosides Nucleotides Nucleic Acids VL - 27 UR - https://doi.org/10.1080/15257770802136032 DO - 10.1080/15257770802136032 ID - Becker2008 ER - TY - JOUR AU - Shaya, F. T. AU - Gbarayor, C. M. AU - Huiwen Keri, Y. AU - Agyeman-Duah, M. AU - Saunders, E. PY - 2007 DA - 2007// TI - A perspective on African American participation in clinical trials JO - Contemp Clin Trials VL - 28 UR - https://doi.org/10.1016/j.cct.2006.10.001 DO - 10.1016/j.cct.2006.10.001 ID - Shaya2007 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2474/13/15/prepub UR - http://www.biomedcentral.com/1471-2474/13/15/prepub ID - ref63 ER -